Hey SP - Journal of Bioethical Inquiry
The future price of a drug should not be ignored during the ethical evaluation of clinical trials, because high drug pricing undermines all three major principles of research ethics: respect for participants who may not benefit from the resulting product, beneficence in risk-benefit assessments, and justice in ensuring future patients can access the treatment.
VIEW SOURCE
Eisenkraft Klein D, Kesselheim AS - Clinical Pharmacology & Therapeutics
Cai CL, Bucha S, Kesselheim AS, Rome BN - Journal of General Internal Medicine
Chen NC, Bullement A, Zemplenyi AT, O'Bryant CL, Kaizer AM, Anderson KE, McQueen RB - PharmacoEconomics Open